Per-Encounter Medical Market Size is valued at USD 121.82 Bn in 2023 and is predicted to reach USD 377.93 Bn by the year 2031 at a 15.38% CAGR during the forecast period for 2024-2031.
Per-encounter medical describes a billing model in which a healthcare practitioner charges a set amount for each patient encounter. This means the patient will always be charged the same amount for each appointment, no matter how long or complicated. This strategy stands in contrast to other payment schemes like capitation and fee-for-service. Under the fee-for-service model, medical professionals charge patients for each treatment they receive. Over a specific period, providers receive a fixed compensation per patient, independent of the number of visits or services provided. Medical billing based on each encounter is common in urgent care centres, walk-in clinics, and treatments requiring regular time and resources.
Furthermore, rising healthcare expenses and an emphasis on value-based care will likely propel the global per-encounter medical industry to steady growth. Payers and providers alike are looking toward pay-for-performance and episode-based payment models to rein in soaring healthcare costs. As a result, more and more people will start paying for each encounter.
However, the market growth is hampered by the high-cost criteria for the safety and health of per-encounter medical and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high humidity per-encounter medical, prices for per-encounter equipment such as syringes, surgical kits, and IV therapy systems are falling due to price pressure from payers, cost-containment initiatives, and unified healthcare systems. Medical device businesses must seek out low-cost manufacturing, regional production, and materials substitution to maintain profit margins. Industry profitability is affected, while market growth is moderated to some extent due to the capacity to charge lower per-unit rates.
The per-encounter medical market is segmented based on product type, application, end-user, and distribution channel. The product type segment is segmented into consumables, devices, software, services, and others. The application segment comprises cardiology, orthopaedics, obstetrics/gynaecology, ophthalmology, gastroenterology, and others. The end-use segment includes hospitals, clinics, diagnostic centres, and others. The distribution channel segment is segmented into direct tender, retail sales, and online sales.
The gastroenterology per-encounter medical market is expected to lead with a major global market share in 2024. A gastroenterologist checks the digestive system for problems, including the smooth passage of food and other substances. Additionally, gastroenterologists are responsible for ensuring normal nutritional digestion and absorption and correctly eliminating waste from the body.
The retail sales industry makes up the bulk of per-encounter medical usage because when retail sales rise, the economy grows well; however, when they fall, it means the reverse. Stock prices tend to rise and benefit shareholders when retail sales increase, especially in countries like the US, Germany, the UK, China, and India.
The North American per-encounter medical market is expected to register the maximum revenue share in the near future. This can be attributed to the area's high rate of chronic diseases, well-developed healthcare system, and welcoming reimbursement rules. In addition, Asia Pacific is estimated to grow rapidly in the global per-encounter medical market due to the growing number of patients, increasing disposable incomes, and better healthcare facilities.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 121.82 Bn |
| Revenue Forecast In 2031 | USD 377.93 Bn |
| Growth Rate CAGR | CAGR of 15.38 % from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product Type, By Application, By End-User, By Distribution Channel |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea |
| Competitive Landscape | Abbott, Cardinal Health, Johnson & Johnson, Medtronic, 3M, Steris, Catalent Inc., Smiths Medical Inc., Schott, Nipro Corporation, Terumo Corporation, Gerresheimer AG, Becton, Dickinson and Company, B. Braun Melsungen AG, AngioDynamics Inc., Teleflex Incorporated, Argon Medical Devices, Inc., ICU Medical, Inc., Medical Components, Inc., Vygon (UK) Ltd, Others |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Per-Encounter Medical Market By Product Type-
Per-Encounter Medical Market By Application-
Per-Encounter Medical Market By End-User-
Per-Encounter Medical Market By Distribution Channel-
Per-Encounter Medical Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.